Annual FCF
-$122.36 M
+$9.28 M+7.05%
December 31, 2024
Summary
- As of March 13, 2025, ALXO annual free cash flow is -$122.36 million, with the most recent change of +$9.28 million (+7.05%) on December 31, 2024.
- During the last 3 years, ALXO annual FCF has fallen by -$49.34 million (-67.56%).
- ALXO annual FCF is now -783.91% below its all-time high of -$13.84 million, reached on December 31, 2018.
Performance
ALXO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$32.11 M
-$6.58 M-25.78%
December 31, 2024
Summary
- As of March 13, 2025, ALXO quarterly free cash flow is -$32.11 million, with the most recent change of -$6.58 million (-25.78%) on December 31, 2024.
- Over the past year, ALXO quarterly FCF has dropped by -$6.58 million (-25.78%).
- ALXO quarterly FCF is now -1041.75% below its all-time high of -$2.81 million, reached on December 31, 2019.
Performance
ALXO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$122.36 M
+$7.72 M+5.93%
December 31, 2024
Summary
- As of March 13, 2025, ALXO TTM free cash flow is -$122.36 million, with the most recent change of +$7.72 million (+5.93%) on December 31, 2024.
- Over the past year, ALXO TTM FCF has increased by +$7.72 million (+5.93%).
- ALXO TTM FCF is now -2975.12% below its all-time high of -$3.98 million, reached on March 31, 2019.
Performance
ALXO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ALXO Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.0% | -25.8% | +5.9% |
| 3 y3 years | -67.6% | -51.0% | -37.3% |
| 5 y5 years | -738.0% | -524.4% | -254.8% |
ALXO Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -67.6% | +7.0% | -86.1% | +19.4% | -67.6% | +13.3% |
| 5 y | 5-year | -738.0% | +7.0% | -1041.8% | +19.4% | -738.0% | +13.3% |
| alltime | all time | -783.9% | +7.0% | -1041.8% | +19.4% | -2975.1% | +13.3% |
ALX Oncology Holdings Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$122.36 M(-7.0%) | -$32.11 M(+25.8%) | -$122.36 M(-5.9%) |
| Sep 2024 | - | -$25.52 M(-4.2%) | -$130.08 M(-3.2%) |
| Jun 2024 | - | -$26.66 M(-30.0%) | -$134.41 M(-4.8%) |
| Mar 2024 | - | -$38.07 M(-4.4%) | -$141.20 M(+7.3%) |
| Dec 2023 | -$131.64 M(+45.2%) | -$39.83 M(+33.4%) | -$131.64 M(+16.6%) |
| Sep 2023 | - | -$29.86 M(-10.7%) | -$112.87 M(-1.1%) |
| Jun 2023 | - | -$33.45 M(+17.3%) | -$114.09 M(+16.5%) |
| Mar 2023 | - | -$28.51 M(+35.4%) | -$97.89 M(+8.0%) |
| Dec 2022 | -$90.65 M(+24.1%) | -$21.06 M(-32.2%) | -$90.65 M(-1.0%) |
| Sep 2022 | - | -$31.07 M(+80.1%) | -$91.60 M(+6.8%) |
| Jun 2022 | - | -$17.25 M(-18.8%) | -$85.78 M(-3.8%) |
| Mar 2022 | - | -$21.26 M(-3.4%) | -$89.14 M(+22.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$73.02 M(+90.6%) | -$22.01 M(-12.9%) | -$73.02 M(+13.0%) |
| Sep 2021 | - | -$25.25 M(+22.5%) | -$64.64 M(+32.1%) |
| Jun 2021 | - | -$20.62 M(+301.1%) | -$48.95 M(+41.9%) |
| Mar 2021 | - | -$5.14 M(-62.3%) | -$34.49 M(-10.0%) |
| Dec 2020 | -$38.32 M(+162.4%) | -$13.63 M(+42.6%) | -$38.32 M(+39.3%) |
| Sep 2020 | - | -$9.56 M(+55.1%) | -$27.51 M(+30.2%) |
| Jun 2020 | - | -$6.16 M(-31.3%) | -$21.13 M(+7.8%) |
| Mar 2020 | - | -$8.97 M(+219.1%) | -$19.60 M(+34.2%) |
| Dec 2019 | -$14.60 M(+5.5%) | -$2.81 M(-11.7%) | -$14.60 M(+23.9%) |
| Sep 2019 | - | -$3.19 M(-31.1%) | -$11.79 M(+37.0%) |
| Jun 2019 | - | -$4.63 M(+16.2%) | -$8.60 M(+116.2%) |
| Mar 2019 | - | -$3.98 M | -$3.98 M |
| Dec 2018 | -$13.84 M | - | - |
FAQ
- What is ALX Oncology Holdings annual free cash flow?
- What is the all time high annual FCF for ALX Oncology Holdings?
- What is ALX Oncology Holdings annual FCF year-on-year change?
- What is ALX Oncology Holdings quarterly free cash flow?
- What is the all time high quarterly FCF for ALX Oncology Holdings?
- What is ALX Oncology Holdings quarterly FCF year-on-year change?
- What is ALX Oncology Holdings TTM free cash flow?
- What is the all time high TTM FCF for ALX Oncology Holdings?
- What is ALX Oncology Holdings TTM FCF year-on-year change?
What is ALX Oncology Holdings annual free cash flow?
The current annual FCF of ALXO is -$122.36 M
What is the all time high annual FCF for ALX Oncology Holdings?
ALX Oncology Holdings all-time high annual free cash flow is -$13.84 M
What is ALX Oncology Holdings annual FCF year-on-year change?
Over the past year, ALXO annual free cash flow has changed by +$9.28 M (+7.05%)
What is ALX Oncology Holdings quarterly free cash flow?
The current quarterly FCF of ALXO is -$32.11 M
What is the all time high quarterly FCF for ALX Oncology Holdings?
ALX Oncology Holdings all-time high quarterly free cash flow is -$2.81 M
What is ALX Oncology Holdings quarterly FCF year-on-year change?
Over the past year, ALXO quarterly free cash flow has changed by -$6.58 M (-25.78%)
What is ALX Oncology Holdings TTM free cash flow?
The current TTM FCF of ALXO is -$122.36 M
What is the all time high TTM FCF for ALX Oncology Holdings?
ALX Oncology Holdings all-time high TTM free cash flow is -$3.98 M
What is ALX Oncology Holdings TTM FCF year-on-year change?
Over the past year, ALXO TTM free cash flow has changed by +$7.72 M (+5.93%)